These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4418941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Characterization of a Chrysemonas luteola strain isolated from a healthy carrier and investigation of pathogenicity, virulence and antibiotic resistance factors through in vitro and in vivo studies].
    Israil A, Balotescu C, Alexandru I.
    Bacteriol Virusol Parazitol Epidemiol; 2004; 49(1-2):43-7. PubMed ID: 16752751
    [No Abstract] [Full Text] [Related]

  • 3. [Pseudomonas maltophilia infections].
    Pintér M, Kántor M.
    Orv Hetil; 1974 Feb 03; 115(5):254-5. PubMed ID: 4839507
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A, Mahapatra A, Padhi S, Mahapatro S, Ghosh SK.
    Indian J Pathol Microbiol; 2006 Oct 03; 49(4):634-5. PubMed ID: 17183885
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Biological characteristics of Pseudomonas species with implications in human pathology].
    Meitert E, Sima F, Savulian C, Chersulick E, Petrescu AM, Meitert M.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986 Oct 03; 31(3):219-34. PubMed ID: 3787084
    [No Abstract] [Full Text] [Related]

  • 8. [Pseudomonas maltophilia in cerebrospinal fluid samples. Isolation, identification and antibiograms of 4 strains].
    Mulinas L, Lorente S, Borras R, Ferrer A, Sanchis-Bayarri Vaillant V.
    Rev Clin Esp; 1986 Oct 03; 146(1-2):31-4. PubMed ID: 897286
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests].
    Pérez Ureña MT, Iriarte MT, Fernández P.
    Rev Clin Esp; 1969 May 15; 113(3):235-40. PubMed ID: 5348710
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical and bacteriological studies on a case with endocarditis due to Pseudomonas cepacia (author's transl)].
    Nishioka K, Honda I, Arai S, Aita H, Takishima T.
    Rinsho Byori; 1979 May 15; 27(7):600-6. PubMed ID: 491262
    [No Abstract] [Full Text] [Related]

  • 13. Study of the incidence of Pseudomonas in gangrenous lesions and its sensitivity to antibiotics and to chemoterapics.
    Brenciaglia MI, Cipriani P, Dainelli B, Mancini C.
    Antibiotica; 1977 Mar 15; 14(1):47-57. PubMed ID: 879717
    [No Abstract] [Full Text] [Related]

  • 14. In vitro antibacterial activity of aminoglycoside antibiotics against Pseudomonas strains.
    Panse MV, Nair KR.
    Hindustan Antibiot Bull; 1981 Mar 15; 23():30-2. PubMed ID: 7309552
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Study of Ps. pycoyanea strains isolated from pathological material.
    Kumari S, Bhatia SL, Agarwal DS.
    Indian J Med Res; 1974 Apr 15; 62(4):484-90. PubMed ID: 4435859
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.